Sign in
BVA Analysis of Low- or High-Dose MCO-010 Optogenetics Therapy for Retinitis Pigmentosa: First Time 100-Week TOPLINE Results From a Phase 2b/3 Clinical trial (RESTORE)
Michael A. Singer, MD
Updates from the Field
2024
Stem Cell Therapy
Mark S. Humayun, MD, PhD
2017
Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio
Keyvan Koushan, MD, FRCSC
Member Podcasts
Category: Inherited retinal diseases